Morbidity and Drug Utilization Pattern of Integrative Medicine (Siddha medicine and Biomedicine) - A Single Center Retrospective Study of 150 Patients doi.org/10.26538/tjnpr/v6i1.5
Main Article Content
Abstract
Integrative Medicine (IM) is a rapidly growing field because of increased demand, which requires further evidence-based research to provide more information on the effectiveness and safety. The aim of the study was to assess morbidity and drug utilization among patients using IM attending Siddha Clinical Research Unit (SCRU), Tirupati, India.The information obtained in the google form, which is the research database of the SCRU, Tirupati, was investigated in this study throughout the time of July to December 2019.The patient demographics, morbidities, commonly used Siddha medications, and biomedicines prescribed at the first visit were studied. Results revealed that most IM users 80 (53.3%) were males, the mean age of IM users was 56.53 years. The most common morbidities were diabetes 95 (63.3%), hypertension 29 (19.3%). Siddha medicines such as Amukkara chooranam 98 (65.3%), Aavarai kudineer 85 (56.6%), were commonly prescribed along with the biomedicine, metformin 91 (60.6%), amlodipine 62 (41.3%). Thus, the common morbidity of the IM users were diabetes and hypertension, common siddha drugs utilized were Amukkara chooranam, Aavarai kudineer, and biomedicine were metformin, amlodipine.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Andrew Weil, What is Integrative Medicine?: Andrew Weil Center for Integrative Medicine [online]. [cited 2021 Apr 17]. Available from:
https://integrativemedicine.arizona.edu/about/definition.html
Patwardhan B. Ayurveda and integrative medicine: Riding a tiger. J Ayurveda Integr Med. 2010; 1(1):13-15.
Thomas KJ, Nicholl JP, Coleman P, Thomas K. Use and expenditure on complementary medicine in England : a population based survey. Comp Ther Med. 2001; 9(1):2-11.
Sawni-sikand A, Schubiner H, Thomas RL. Use of Complementary/Alternative Therapies Among Children in Primary Care ediatrics.Ambulatory Pediat. 2002; 2(2):99-103.
Tamil Nadu Dr. M.G.R Medical University, Chennai, Department of Siddha, [online]. [cited 2021 Dec 28]. Available from:https://www.indcareer.com/tamil-nadu-drmgr-medical-university-chennai/Departments/departmentsiddha.
Ministry of Ayush | Home [Internet]. [cited 2021 Dec 15]. Available from: https://dashboard.ayush.gov.in/
Noncommunicable diseases [Internet]. [cited 2021 Dec 15].Available from: https://www.who.int/news-room/factsheets/detail/noncommunicable-diseases
Merlin VK. Manickavasakam. The combined effect of siddha medicines in the treatment of naakku putru noi ( squamous cell carcinoma of the tongue ). Int J Pharm Pharm Sci. 2014; 6(1):38-39.
By P, Sanskriti DEV, Mishra A, Batham L, Shrivastava.Yagya Therapy as supportive care in cancer patients improved quality of life : Case studies. Interdiscip J Yagya Res. 2018; 1(1):26-33.
Engdal S, Steinsbekk A, Klepp O. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer. 2008; 16(7):763-769.
Samraj K, Nandhagopal K, Radha S, Rajalakshmi S, Arunachalam K, Annual Report 2019-2020, Siddha Clinical Research Unit, Tirupati 16-24.
Srikumar R, Parthasarathy NJ, Manikandan S,Govindarajulu SN, Rathinasamy S, Effect of Triphala on oxidative stress and on cell-mediated immune response against noise stress in rats. Mol Cell Biochem. 2006; 283:67-74.
Gurjar S, Pal A, Kapur S. Triphala and its constituents ameliorate visceral adiposity from a high-fat diet in mice with diet-induced obesity. AlternTher Health Med. 2012; 18(6):38-45.
atel DK, Kumar R, Laloo D, Hemalatha S. Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed. 2012; 2(5):411-420.
Biradar YS, Jagatap S, Khandelwal KR, Singhania SS. Exploring of antimicrobial activity of TriphalaMashi—An ayurvedic formulation. Evid-Based Comp Altern Med. 2008; 5(1):107-113.
Sandhya T, Lathika KM, Pandey BN, Mishra KP. Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett. 2006; 231(2):206-214.
Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM, Mohan H. In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res.2005; 19(7):582-586.
Peterson CT and Denniston K. Therapeutic Uses of Triphala in Ayurvedic Medicine. J alternat complement med. 2017; 23(8):607-614.
Jain J, Narayanan V, Sunil S. In Vivo Evaluation of Withania somnifera – Based Indian Traditional Formulation ( Amukkara Choornam ), Against Chikungunya Virus –Induced Morbidity and Arthralgia. J Evid-Based Integr Med. 2018; 23:1-7.
Shafreen B and Seema R. Modulatory effects of Amukkara Choornam on Candida albicans biofilm : in vitro and in vivostudy. Mol Biol Rep. 2019; 46(3):2961-2969.
Rajalakshmi K, Christian GJ, ShanmugaPriya P, Jeeva Gladys R. Validation of Anti-diabetic Potential of Avirai kudineer a Siddha herbal. IOSR J Dent Med Sci. 2019; 14(7):7-15.
Rajalakshmi K, Shanmugapriya P, Christian GJ. Antimicrobial Potential of Siddha Polyherbal Formulation Aavarai Kudineer. J Pure Appl Microbiol. 2018; 12(2):1019-1025.
Keerthana VAJ (2019). A comparative clinical trial of siddha formulation of nilavaagai chooranam ( internally ) and thengaai thylam ( externally ) in the treatment of ‘ karappan ’ ( eczema ) with and without leech therapy. [Doctoral dissertation, Tamilnadu Dr. MGR Medical
University], Institutional repository of Tamilnadu Dr. MGR Medical University, http://repository-tnmgrmu.ac.in/12129/.
Ram M, Rao K, Prasbhu K. Antioxidant Study and GC MS Analysis of an Ayurvedic Medicine ‘Talisapatradi Choornam. Int J Pharm Sci Rev Res. 2016; 36(1):158-166.
Archana K, Mahadevan MV, Mahalakshmi V, Muthukumar NJ, In vitro pharmacological screening of Parangipattai Kudineer Chooranam-a herbal formulation used for Kalanjagapadai (Psoriasis), J Res Biomed Sci, 2(4); 2019: 51-57.
Sudharshini K, Anto S, Saravanan D, Selvaraj R. Antimicrobial Activity of Selected Chooranams (Poonaikali, Ponnavarai, Gunma Uppu, Parangipattai) against Drug Resistant Pathogens. Int J Pharm Sci Rev Res. 2017; 46(1):139-145.
Vinodini R, Amala Hazel AM, Meenakshi Sundaram M, Muthukumar NJ. Clinical Evaluation of Parangipattai chooranam (internal) and Annabedhi chenduram (external) for Venpulli (Vitiligo) in children. Res J Pharm Technol. 2019; 12(12): 5932-5936.
Nalini Sofia H, Vetha Merlin KH, Manickavasakam K, Raja Rajeswari P. Efficacy of Karpoora Silasatthu Parpam in The Management Of Azhal Kalladaippu (Renal Calculi).Int. J Adv Res. 2019; 7(2):231-41.
Alam N, Gopal V, Vasanthi C, Manna PK. Nephroprotective potential of Neermulli / Nerunjil Kudineer on Cisplatin induced nephrotoxicity in Wistar albino rats. Int J Res Pharm Sci. 2019; 10(3):1720-1729.
Satish S, Periasamy P, Namasivayam A. Effect of Tribulus terrestris on Experimental Urolithiasis Induced by Ethylene Glycol in Albino Rats. Pharm Sci. 1996; 2(9):437-439.
Jayaraman B, Gnanamani A, Stanley A, Stanley SA. In vivo preclinical evaluation of rasagenthi mezhugu , a siddha formulation , on anti cancer potential in balb / c mice with ct26 murine colon carcinoma. Indo Am J Pharm. 2017; 3(5):266-277.
Álvaro M, Lins DF, Andreia K, Moreno M, Carlos R, Maria S. Constipation prevalence in diabetic patients. J Coloproctol. 2014; 34(2):83-86.
US FDA. Clinical drug interaction studies —cytochrome P450 enzyme- and transporter-mediated drug interactions. Guidance for industry Cited 2020 Oct 18). Available from: https//www.fda.gov/media/134581/download.